Ai Pharmacovigilance

Research Frontiers in Mixture Density Networks for Adverse Event Risk Distribution Modeling

Implementation of mixture density networks to model complex, multimodal distributions of adverse event risk across heterogeneous patient populations.

All AI Pharmacovigilance PhD categories